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Attention-deficit/hyperactivity disorder (ADHD) has been associated with an increased risk
of tobacco smoking, and more difficulties with smoking cessation compared to non-ADHD
individuals. Women with ADHD may therefore show elevated rates of smoking during
pregnancy.
Aims
To examine the association between ADHD and smoking habits among pregnant women in
Sweden and Norway.
Methods
Women pregnant for the first time were identified in Sweden (n = 622,037), and Norway (n =
293,383), of which 1.2% (n = 7,444), and 1.7% (n = 4,951) were defined as having ADHD,
respectively. Data on smoking habits were collected early and late in pregnancy.
Results
In Sweden, ADHD was associated with an increased risk of smoking early in pregnancy,
adjusted risk ratio (adjRR) 2.69 (95% confidence interval, 2.58–2.81), and late in pregnancy,
adjRR 2.95 (2.80–3.10). Similar findings were observed in the Norwegian data, early in
pregnancy, adjRR 2.31 (2.21–2.40), and late in pregnancy, adjRR 2.56 (2.42–2.70).
Women with ADHD were more likely to continue smoking during pregnancy, compared to
women without ADHD, both in Sweden adjRR 1.13 (1.10–1.17), and in Norway, adjRR 1.16
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(1.12–1.20). Having a sibling diagnosed with ADHD was associated with an increased risk
of smoking early and late in pregnancy, in both Sweden and Norway.
Conclusions
Women with ADHD are considerably more likely to smoke early and late in (their first) preg-
nancy and are less likely to stop smoking between the two time points. Smoking, early and
late in pregnancy, co-aggregates in families with ADHD. Smoking prevention and interven-
tion programs should be targeted towards women with ADHD, specifically during their child-
bearing years, to ensure better mother and child outcomes.
Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disor-
der with a strong genetic component [1], that often debuts during childhood and may persist
into adulthood [2,3]. Several health-risk behaviors are common among individuals with
ADHD [4], including smoking [5]. Adolescents and adults diagnosed with ADHD are about
twice as likely to smoke compared to individuals without ADHD [6,7]. Individuals diagnosed
with ADHD are also more likely to report earlier smoking initiation and become daily smokers
compared to individuals without ADHD [8]. However, some of these studies are based on rela-
tively small and non-representative selected samples thus the knowledge of the burden of
smoking among individuals diagnosed with ADHD is still limited.
Smoking during pregnancy is considered a serious, avoidable risk behavior that is believed
to increase the likelihood of adverse pregnancy related outcomes in both the mother and the
child. For example, maternal smoking during pregnancy increases the risk of low birth weight
[9,10], and preterm birth [11], results that also have been validated in genetically sensitive
designs [12]. Maternal smoking during pregnancy has also been associated with an increased
risk of stillbirth [13] and infant mortality [14]. It is further estimated that 6% of global female
deaths are due to smoking [15]. A recent study reported more nicotine dependence and higher
cigarette consumption in women compared to males diagnosed with ADHD [16]. It has also
been demonstrated that individuals with ADHD experience more difficulties with smoking
cessation compared to individuals without ADHD [8]. Women with ADHD may therefore
show elevated rates of smoking during pregnancy.
Like ADHD [17], smoking habits [18] also tend to aggregate within families, i.e., one indi-
vidual’s smoking increases the risk of his/her family members to also engage in smoking. How-
ever, whether ADHD and smoking co-aggregates is currently not known. A large molecular
genetic study demonstrated positive genetic correlations between ADHD and smoking habits
[19], and ADHD polygenic scores have been found to be associated with more smoking during
pregnancy [20]. However, these findings need to be replicated in other settings (e.g., pregnant
women), using other study designs (e.g., familial co-aggregation study).
To attain more knowledge regarding ADHD and smoking during pregnancy, we used pop-
ulation-based register data from Sweden and Norway to examine the associations between
ADHD and smoking during pregnancy, using a cohort design. We addressed the following
three research questions:
1. Are women diagnosed with ADHD more likely to smoke during their first pregnancy com-
pared to women without ADHD?
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2. Are women diagnosed with ADHD more likely to continue smoking during pregnancy,
compared to women without ADHD?
3. Do ADHD and smoking during pregnancy co-aggregate in families?
Methods
Study population Sweden
The Medical Birth Register of Sweden (MBRS) was established in 1973 with the purpose of col-
lecting health data on all Swedish pregnancies [21]. In Sweden, as in the other Nordic coun-
tries, each individual residing in the country has a unique personal identification number
(PIN) that permits linkage between public registers and databases.
Based on compulsory notification, the MBRS includes information on all live births and
stillbirths (from 28 gestational weeks until 2008, and from 22 gestational weeks thereafter). We
used the MBRS to identify all unique singleton pregnancies between 2000 and 2013
(n = 856,096). We excluded women with missing information on the PIN, birth year, or parity
(n = 7). We further restricted the sample to women who were pregnant for the first time,
resulting in 622,037 pregnancies (of which n = 2,277 (0.4%) ended in stillbirth). Next we used
the Swedish Multi-Generation Register [22] to link the index women to their full siblings. We
only included first pregnancies to avoid correlated data, i.e., same mother contributing with
data more than once. We further only included singletons due to potential differences on fol-
low-up in multiparous pregnancies.
This study was approved by the Regional Ethical Review board in Stockholm, Sweden
(DNR: 2013/862-31/5).
Study population Norway
The Medical Birth Registry of Norway (MBRN) is a mandatory population-based register
established in 1967 to record information on all pregnancies in Norway from 16th gestational
week, and from the 12th gestational week from 2002 [23]. Maternal smoking habits have been
available in the registry since December 1998. We used the MBRN to identify all unique single-
ton pregnancies between 1999 and 2012 (n = 488,745). We excluded women with missing
information on PIN, birth year, or parity (n = 7,583), and those that had died or emigrated
prior to 2004 (n = 1,998) which was the year that the Norwegian Prescription Database
(NorPD) was established. We restricted the sample to only include women who were pregnant
for the first time leaving us with a total of 293,383 pregnancies (of which n = 1,599 (0.5%)
ended in stillbirth). The MBRN was further used to identify the siblings of the pregnant
women.
The Western Norway Regional Ethics Committee has approved the use of the Norwegian
data for this study (2011/2272).
Smoking Sweden
The MBRS has collected information on maternal smoking at the first antenatal visit (usually
during the first trimester) since 1983, and smoking habits in week 30–32 since 1991. Due to a
high proportion of missing smoking information in week 30–32, data for this point in preg-
nancy has only been available for research since 2000 [21]. Smoking habits are collected by
midwives, using self-reports, and registered as: “not smoke”, “1–9 cigarettes/day” or “more
than 9 cigarettes/day”. We dichotomized smoking habits by defining “not smoke” as “non-
PLOS ONE ADHD and smoking in pregnant women
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smoking” whereas “1–9 cigarettes/day” or “more than 9 cigarettes/day” was defined as “smok-
ing”. Smoking at the first antenatal visit and in week 30–32 will be referred to as smoking early
in pregnancy and late in pregnancy.
Smoking Norway
Since December 1998, the MBRN has collected information on smoking at the first antenatal
visit (in the first trimester, gestational week 0–12) and in the last trimester (from gestational
week 29). Information on smoking is obtained by a physician or a midwife during antenatal
care where a pregnant woman is defined as a “non-smoker”, “occasional, but not daily
smoker” or “daily smoker”. We defined smoking in the first and last trimester as early versus
late in pregnancy. To harmonize the Swedish and Norwegian data, the smoking variables
“non-smoker” and “occasional, but not daily smoker” were defined as “non-smoking” while
“daily smoker” was defined as “smoking”.
ADHD Sweden
The Swedish National Patient Register (SNPR) [24] provides complete information on all psy-
chiatric inpatient care since 1987, and outpatient care from 2001. The Swedish Prescribed
Drug Register (SPDR) was established in 2005 and contains data on dispensed medication
[25]. Women (and their full siblings) were defined as having ADHD if they had ever received a
diagnosis of ADHD in the SNPR (International Classification of Disease (ICD-9: 314 or ICD-
10: F90) or ever been dispensed a drug (SPDR) used almost exclusively in the treatment of
ADHD (Anatomical Therapeutic Chemical (ATC) codes: methylphenidate (N06BA04),
amphetamine (N06BA01), dexamphetamine (N06BA02), atomoxetine (N06BA09), or lisdex-
amphetamine (NO6BA12)). This resulted in a total of 7,444 (1.2%) women being defined as
having a diagnosis of ADHD. We used SNPR data from 1987 to 2013 and SPDR data from
2005 to 2013.
ADHD Norway
The Norwegian Patient Registry (NNPR) was established in 1997 but has only included unique
PINs for registered patients since 2008 and can therefore only be linked with other registers
since that year. It covers inpatient and outpatient specialist somatic and psychiatric health care
in Norway [26]. The Norwegian Prescription Database (NorPD) was established in 2004 and
collects information on dispensed drug prescriptions from all Norwegian pharmacies includ-
ing the indication for reimbursed medication, partly since 2004 and completely since 2008
[27]. Women were defined as having ADHD if they had ever received a diagnosis of ADHD
(ICD-10: F90) in the NNPR or had ever been dispensed an ADHD-specific drug (methylphe-
nidate (N06BA04), amphetamine (N06BA01), dexamphetamine (N06BA02), atomoxetine
(N06BA09), or lisdexamphetamine (NO6BA12)). For the years 2008–2016 we also required
that the indication for drug prescription was ICD-10: F90 or ICPC: P81. In total, 4,951 (1.7%)
of the women were defined as having ADHD. We used NNPR data from 2008 to 2016 and
NorPD data from 2004 to 2016. As in Sweden, linkage between the registers was based on
anonymized PINs.
Covariates in Sweden and Norway
Information on the year of childbirth was retrieved from the MBRS (2000–2013) and the
MBRN (1999–2012) in order to adjust for potential period effects since both smoking preva-
lence and diagnostic practises may have changed over time.
PLOS ONE ADHD and smoking in pregnant women
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Socioeconomic Status (SES) has been shown to be associated with both smoking [28] and
ADHD [29] with lower SES being associated with higher smoking rates [30], and smoking ces-
sation less likely to be successful [31]. SES could therefore act as a confounder (or a mediator)
in the association between ADHD and smoking. We used data from the Longitudinal Integra-
tion Database for Health Insurance and Labour Market (LISA) [32], and the National educa-
tion database of Norway to define a proxy measure of SES as the highest recorded level of
education achieved by the mothers of the primiparous women. This variable was categorized
as: <9 years: 1; 9 years: 2; 10–11 years: 3; 12 years: 4; 13–14 years: 5; 15 years: 6;>15 years: 7
and will be referred to as maternal education.
ADHD is highly comorbid with other psychiatric conditions [33,3], therefore we defined
women to have been diagnosed with any comorbid psychiatric disorder if they had been diag-
nosed with any non-ADHD/non-tobacco-addiction psychiatric disorder in the SNPR or in the
NNPR (see Table 1).
Statistical analyses
Data management and descriptive analyses were performed with SAS software version 9.4
(SAS Institute Inc., Cary, NC), R and R Studio. We used logistic regression and regression
standardization with the stdReg-package to estimate risk ratios (RRs) and 95% confidence
intervals. In the logistic regression models, ADHD was the predictor and smoking early and
late in pregnancy were the outcomes. Unadjusted estimates may be more appropriate for clini-
cal prediction, while adjusted estimates might be more informative under a causal framework.
Therefore, both unadjusted and adjusted estimates will be presented.
1. First, we estimated the prevalence and association between ADHD and smoking in preg-
nant women with versus without ADHD. Second, we adjusted for maternal education and
year of childbirth. Third, we adjusted for psychiatric comorbidities.
2. We defined women who reported that they smoked at two consecutive measurements (i.e.,
early in pregnancy and late in pregnancy) as continued smokers. Women with only one
measurement of smoking during pregnancy were excluded. Thus, we could compare the
rate of continuous smoking through the pregnancy in women diagnosed with versus with-
out ADHD, while adjusting for maternal education, year of childbirth and psychiatric
comorbidities.
3. We assessed the familial co-aggregation of ADHD and smoking during pregnancy, i.e.,
whether there was an association between smoking during pregnancy and having a full sib-
ling with ADHD, while adjusting for period effects and ADHD in the index women (which
in principle corresponds to excluding index women with ADHD). We further examined
the absolute risk and risk difference of smoking during pregnancy in those women with
versus without a sibling diagnosed with ADHD to help guide clinical prediction and deci-
sion making.
Table 1. ICD codes included in the combined covariate any psychiatric disorder.
Disorders
ICD-9 codes ’291’ ’292’ ’293’ ’294’ ’295’ ’296’ ’297’ ’298’ ’299’ ’300’ ’301’ ’302’ ’303’ ’304’ ’306’ ’307’ ’308’ ’309’ ’310’
’311’ ’312’ ’313’ ’315’ ’316’ ’317’ ’318’ ’319’ ’305A’ ’305X’
ICD-10
codes
’F2’ ’F3’ ’F4’ ’F5’ ’F6’ ’F7’ ’F8’ ’F10’ ’F11’ ’F12’ ’F13’ ’F14’ ’F15’ ’F16’ ’F18’ ’F19’ ’F91’ ’F92’ ’F93’ ’F94’
’F95’ ’F98’ ’F99’
https://doi.org/10.1371/journal.pone.0234561.t001
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Results
The demographic properties of the Swedish and the Norwegian cohorts are presented in
Table 2.
Are women diagnosed with ADHD more likely to smoke during their first
pregnancy compared to women without ADHD?
In Sweden, a total of 33.0% of the women with ADHD smoked early in pregnancy, compared
to 7.3% in those without ADHD, equivalent to an unadjusted risk ratio (RR) of 4.55 (4.40–
4.71). Moreover, 25.9% of the women with ADHD smoked late in pregnancy compared with
4.9% of the women without ADHD, RR = 5.33 (5.10–5.56). Similar results were noted in Nor-
way where 44.5% of the women with ADHD smoked early in pregnancy, compared to 15.0%
in those without ADHD, equivalent to an unadjusted RR of 2.96 (2.86–3.06). Moreover, 31.1%
of women with ADHD reported that they smoked late in pregnancy compared with 8.9% of
the women without ADHD, RR = 3.48 (3.31–3.64) (Table 3).
In Sweden, after adjustment for maternal education, and year of childbirth, women with
ADHD were still significantly more likely to smoke early in pregnancy adjRR = 4.40, (4.25–
4.55), and late in pregnancy adjRR = 5.17, (4.94–5.39), compared to women without ADHD.
Similar results were found in Norway, where women with ADHD were significantly more
likely to smoke early in pregnancy adjRR = 2.72 (2.62–2.82), and late in pregnancy
adjRR = 3.21 (3.06–3.37), compared to women without ADHD. Further adjustment for any
other psychiatric disorders attenuated these associations, but the results remained robust in
both Sweden [early in pregnancy adjRR = 2.69 (2.58–2.81), and late in pregnancy adjRR = 2.95
(2.80–3.10)], and Norway [early in pregnancy adjRR = 2.31 (2.21–2.40) and late in pregnancy
adjRR = 2.56 (2.42–2.70)] (Table 3).
Table 2. Study characteristics for Sweden and Norway.
Sweden Norway
Variables ADHD (%) Non-ADHD (%) ADHD (%) Non-ADHD (%)
Missing Smoking
Early in pregnancy 417 (5.6) 31,510 (5.1) 667 (13.5) 50,107 (17.4)
Late in pregnancy 1,122 (15.1) 49, 603 (8.1) 857 (17.3) 59,917 (20.8)
Maternal education, years
<9 years 413 (5.8) 50,520 (9.7) 6 (0.1) 773 (0.4)
9 years 1,205 (17.1) 61,272 (11.7) 1,689 (38.0) 57,706 (26.0)
10–11 years 2,983 (42.3) 200,153 (38.3) 1,001 (22.5) 70,869 (31.9)
12 years 872 (12.3) 55,961 (10.7) 852 (19.2) 36,028 (16.2)
13–14 years 725 (10.3) 66,619 (12.7) 95 (2.1) 4,914 (2.2)
15 years 830 (11.8) 84,980 (16.3) 741 (16.7) 46,680 (21.0)
>15 years 30 (0.4) 2,899 (0.6) 59 (1.3) 5,281 (2.4)
Psychiatric Comorbidity�
Depression 3,537 (47.5) 35,184 (5.7) 1,520 (30.1) 20,167 (7.0)
Substance use disorder 2,219 (29.8) 16,013 (2.6) 853 (17.2) 3,976 (1.4)
Bipolar disorder 1,167 (15.7) 4,424 (0.7) 396 (8.0) 2,451 (0.8)
Personality disorders 1,563 (21.0) 5,912 (9.6) 628 (12.7) 3,243 (1.1)
Schizophrenia 259 (3.5) 2,346 (0.4) 90 (1.8) 1,034 (0.4)
Any psychiatric disorder� 6,296 (84.6) 88,134 (14.3) 3,311 (67.0) 50,114 (17.4)
�Sum is more than 100% as some women will have more than 1 additional disorder.
https://doi.org/10.1371/journal.pone.0234561.t002
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Are women diagnosed with ADHD more likely to continue smoking during
pregnancy, compared to women without ADHD?
In Sweden, women with ADHD had an increased risk of continued smoking during pregnancy
(e.g. reported smoking both early in pregnancy and late in pregnancy) adjRR = 1.19 (1.16–
1.22), compared to women without ADHD. Similar results were found in Norway
adjRR = 1.20 (1.16–1.24). With further adjustment for any other psychiatric disorders in both
countries, the associations were somewhat attenuated but were still present (Table 4).
Do ADHD and smoking during pregnancy co-aggregate in families?
In Sweden, women who had a sibling diagnosed with ADHD were more likely to smoke both
early (adjRR = 2.16, 2.07–2.25) and late in pregnancy (adjRR = 2.36, 2.24–2.49), compared to
women without a sibling diagnosed with ADHD, after adjusting for ADHD in the index
women. The absolute risk of smoking early in pregnancy in women with a sibling diagnosed
with ADHD was 18.0%, with a risk difference of 10.4%-points compared to women without a




Unadjusted RRs Adjusted RRs� Adjusted RRs��
Total Non-
ADHD











564,990 6,322 27,498 (4.9) 1,639
(25.9)








238,325 4,284 35,836 (15.0) 1,907
(44.5)







228,515 4,094 20,441 (8.9) 1,273
(31.1)





�Adjusted for year of childbirth, and maternal education
��Adjusted for year of childbirth, maternal education, and psychiatric comorbidity.
https://doi.org/10.1371/journal.pone.0234561.t003
Table 4. Association between ADHD and continued smoking in women with ADHD compared to women without ADHD, in Sweden and Norway. Women with













Non-ADHD ADHD RR (95% CI) RR (95% CI) RR (95% CI) P value
Sweden
Smoking early and late in
pregnancy










Smoking early and late in
pregnancy









�Adjusted for year of childbirth, and maternal education
��Adjusted for year of childbirth, maternal education, and psychiatric comorbidity.
https://doi.org/10.1371/journal.pone.0234561.t004
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sibling with ADHD. Corresponding absolute risk of smoking late in pregnancy was 13.8%,
with a risk difference of 8.6%-points.
Similar results were found in Norway. Women who had a sibling diagnosed with ADHD
were more likely to smoke early in pregnancy (adjRR = 1.61, 1.53–1.69) and late in pregnancy
(adjRR = 1.80, 1.69–1.92), compared to women without a sibling diagnosed with ADHD, after
adjusting for ADHD in the index women. The absolute risk of smoking early in pregnancy in
women with a sibling diagnosed with ADHD was 26.0%, with a risk difference of 10.8%-points
compared to women without a sibling with ADHD. Corresponding absolute risk late in preg-
nancy was 17.5%, with a risk difference of 8.5%-points (Table 5).
Discussion
In this cross-nation population-based study, we demonstrate that a diagnosis of ADHD was
strongly associated with smoking during pregnancy in both Sweden and Norway, even after
adjusting for maternal education, year of childbirth and the presence of comorbid psychiatric
disorders. In comparison to pregnant women without ADHD, pregnant women diagnosed
with ADHD were also more likely to report smoking both early and late in pregnancy. Our
study further demonstrated that smoking both early and late in pregnancy co-aggregates in
families with ADHD. These findings show that among women, ADHD is a strong and clini-
cally relevant predictor of smoking during pregnancy.
Our first finding that women with ADHD were considerably more likely to smoke in their
first pregnancy compared to women without ADHD, is in line with previous research on non-
pregnant study populations [8]. Women with ADHD are more likely to become pregnant dur-
ing their teenage years [34] and have an earlier smoking initiation [8] indicating that adoles-
cent girls and young women with ADHD may be a vulnerable group in need of support. Thus,
our finding highlights the importance of early intervention and counseling by health care pro-
viders to help prevent the development of regular and established smoking habits in women
diagnosed with ADHD. Smoking cessation would benefit both immediate and long-term out-
comes in the mother and child.
Our second main finding indicates that women diagnosed with ADHD are more likely to
continue smoking throughout pregnancy compared to women without ADHD as they were
more likely to report smoking at the two consecutive time-points (early and late in pregnancy).
Previous research has suggested that these differences in smoking cessation may be the result
of greater withdrawal severity in individuals with ADHD compared to those without ADHD
[6]. Smoking cessation early in pregnancy reduce the risk of stillbirth and prematurity to the
level of non-smokers [35]. This highlights the need for better smoking cessation interventions
for pregnant women with ADHD who smoke.
Table 5. Association between having a sibling diagnosed with ADHD and smoking during pregnancy in women, in Sweden and Norway.
Unique siblings Adjusted� Absolute Risk % Risk Difference %
With ADHD Without ADHD RR (95% CI) P value Non-ADHD Sibling ADHD Sibling
Sweden
Smoking early in pregnancy 418,536 11,807 2.16 (2.07–2.25) <0.001 7.6 (7.5–7.7) 18.0 (17.3–18.8) 10.4 (9.7–11.2)
Smoking late in pregnancy 343,466 9,881 2.36 (2.24–2.49) <0.001 5.2 (5.1–5.3) 13.8 (13.1–14.5) 8.6 (8.0–9.3)
Norway
Smoking early in pregnancy 232,705 5,679 1.61 (1.53–1.69) <0.001 15.2 (15.0–15.4) 26.0 (24.8–27.2) 10.8 (9.6–12.0)
Smoking late in pregnancy 224,111 5,462 1.80 (1.69–1.92) <0.001 8.9 (8.8–9.1) 17.5 (16.4–18.5) 8.5 (7.5–9.6)
�Adjusted for year of childbirth, and ADHD in index women.
https://doi.org/10.1371/journal.pone.0234561.t005
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Our third finding demonstrated that smoking during pregnancy and ADHD co-aggregate
in families. Having a sibling with ADHD increases the risk of smoking during pregnancy in
women that do not have ADHD themselves, indicating a shared familial liability to both
ADHD and smoking during pregnancy. This is in line with recent findings of genetic correla-
tions between ADHD and several smoking-related traits, including lung cancer [19] as well as
a study that reported an association between an ADHD polygenic score and smoking during
pregnancy [20]. Of clinical interest, the familial co-aggregation of ADHD and smoking dem-
onstrates that a family history of ADHD may be used by health care providers to identify
women that might be in need for additional support and help with smoking cessation. Our
findings may also generalize to outside of pregnancy situations. Therefore, our findings sug-
gest that a family history of ADHD could be used to identify children and adolescents that are
at risk of starting smoking.
It is important to highlight that there are several potential mechanisms underlying the asso-
ciation seen between ADHD and smoking while pregnant. Both ADHD and smoking are
known to be highly heritable [36,37]. Previous research has also found genetic markers associ-
ated with both ADHD and smoking [38,39,40,41]. This suggests that neurobiological factors
that contribute to ADHD symptoms also contributes to an individual’s risk to commence and
continue smoking [42]. Behavioral risk factors, such as deficient impulse-control could in
addition to genes potentially explain why individuals diagnosed with ADHD are more prone
to engage in adverse health behaviors, such as smoking and other types of substance abuse.
Further, several social influences (e.g., smoking habits in family and friends) could also
increase the risk for smoking in ADHD individuals [43].
Strengths and limitations
By using population-based registries with compulsory notification, our study is not limited by
restrictions in statistical power, and unlikely to suffer from selection bias. The results in the
present study shows that the association between ADHD and smoking during pregnancy is
robust across Nordic nations. It is, however, important to note that a higher proportion of
women with and without ADHD smoke in Norway compared to Sweden (see S1 and S2 Figs).
The higher smoking prevalence in Norway likely reflects true differences across countries, and
between registries. For example, smoking during pregnancy has been higher in Norway com-
pared to Sweden in previous years [44] Yet, it seems as if smoking during pregnancy has
reduced more in Norway compared to Sweden [44]. In addition to the time periods not
completely matching (as we sought to maximize the statistical power in our study given the
data available to us), women in Norway can refrain from having their smoking data registered,
leading to a higher number of missing values on the smoking variables compared to Sweden.
Another strength includes the large datasets and the possibilities to adjust for other psychiat-
ric disorders in an effort to investigate whether it is ADHD itself, or common psychiatric
comorbidities, that “drive” the association between ADHD and smoking during pregnancy.
However, there could be limitations in these assumptions as other traits, including somatic dis-
eases, may impact both ADHD severity and adverse health behaviors. Yet, these psychiatric dis-
orders frequently co-occur with ADHD and seemed appropriate based on previous studies [45].
Another strength of the study is our definition of ADHD. This definition has previously
been shown to have a high correlation with ADHD symptoms (derived from the Swedish twin
register) [46]. However, it is important to mention that the use of clinical diagnoses of ADHD
in the Swedish and Norwegian registers likely captures the more burdened ADHD cases.
The registers also enabled us to conduct sensitivity analyses to exclude some alternative
explanations. For some women, the definition of the predictor will be after the definition of
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the outcome. However, as ADHD is considered being a neurodevelopmental disorder present
from young age (1,2) it is likely that the predictor was present before the outcome of interest
(smoking early and late in pregnancy). Sensitivity analyses restricted to first pregnancies
between 2007 and 2013, where the ADHD definition only included women who were defined
as having ADHD prior to becoming pregnant, revealed largely unchanged results (results not
presented). This indicates that bias from period effects as well as the risk of reverse causation,
are unlikely to influence the associations seen between ADHD and smoking during pregnancy.
Additionally, we were able to demonstrate that factors surrounding artificial fertilization (e.g.,
smoking cessation may be mandatory) did not substantially alter our results. We were also
able to demonstrate that ADHD-medication during pregnancy did not introduce a substantial
amount of bias to our estimates (results for these two separate analyses are not shown).
In this study, we treated women who reported no daily smoking as non-smokers, which
could lead to some misclassification. Consequently, women who smoke occasionally, but not
on a daily basis, were included in the non-smoker category. However, sensitivity analysis from
the Norwegian data, where both “daily smokers” and “occasional, but not daily smoker” were
treated as smokers lead to largely similar results as the main analyses (results not presented),
which further supports our findings. Further, the stigma surrounding smoking during preg-
nancy might lead to underreporting. However, high agreement between the smoking informa-
tion in the MBRS and maternal serum cotinine has previously been reported [47].
Finally, by investigating smoking late in pregnancy, we could demonstrate that women
diagnosed with ADHD were more likely to continue smoking throughout pregnancy, com-
pared to women without ADHD. In the present study, we assumed that women who smoked
at the two consecutive time points represented women that continued to smoke through the
whole time-period. Importantly, we did not have information about periods without smoking
in-between the time-points. However, we believe it is unlikely that more detailed information
would have led to a conclusion different from the one presented in our study, namely that
among pregnant women who smoke in the beginning of pregnancy, those with ADHD have a
higher risk of being daily smokers also late in pregnancy.
Conclusions
To conclude, our large cross-nation population-based study indicates that women with
ADHD are more likely to smoke both in the beginning and at the end of the pregnancy and
have a lower likelihood of smoking cessation during pregnancy, compared to women without
ADHD. Having a sibling with ADHD is associated with an increased likelihood of smoking
during pregnancy suggesting a shared familial liability. The considerably increased risk of
smoking throughout pregnancy among women with ADHD highlights the importance of
early interventions and professional support to this group, especially as smoking avoidance
and/or cessation would ensure better mother and child-outcomes.
Supporting information
S1 Fig. Proportion of smoking early in pregnancy among those with versus without
ADHD, in Sweden.
(DOCX)
S2 Fig. Proportion of smoking early in pregnancy among those with versus without
ADHD, in Norway.
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